tradingkey.logo
tradingkey.logo
Search

Summary

Yulia Zeng is a finance editor at TradingKey. With a background in finance, she has previously worked at banks and brokerage firms, where she was responsible for writing news articles related to global investment products including stocks, indices, foreign exchange, and commodities.

Areas of Expertise

  • Market Insights: Keenly captures movements in the U.S. stock market, focusing on hot news and thematic analyses.

  • Individual Stock Analysis: Deeply researches U.S. stocks, combining industry trends, financial report data, and policy dynamics, balancing fundamental and market sentiment analysis.

  • Macro Interpretation: Focuses on Federal Reserve monetary policy, U.S. economic data, and policy changes.

Experience

TradingKey|Financial Editor 2025 – Present · Shenzhen Responsible for writing news coverage related to stocks, indices, forex, and commodities across global investment Instruments

Total 1053 articles

Samsung Set for 10 Trillion Won Q3 Profit as AI Demand Sparks Memory Price Rally

TradingKey - Global memory chip leader Samsung Electronics will announce its preliminary third-quarter 2025 results on Tuesday, October 14, with high market expectations. Analysts predict that thanks to strong recovery in server demand driven by customer inventory rebuilding and the resulting...
Oct 13, 2025

After Pfizer, AstraZeneca Strikes Drug Price Pact with Trump — Who’s Next to Capitulate?

TradingKey - U.S. President Trump announced on Friday that British pharmaceutical giant AstraZeneca has reached a major drug pricing agreement with the government, marking the second significant deal following a similar agreement with Pfizer last week.
Oct 11, 2025

Trump's 100% China Tariffs Trigger Crypto Carnage, Digital Assets Nosedive

TradingKey - Friday, US President Trump announced 100% tariffs on Chinese goods, triggering a historic sell-off in crypto assets as the global cryptocurrency market cap plummeted 10.27% within 24 hours, falling below the $4 trillion mark.
Oct 11, 2025

Novo Nordisk's New CEO Makes $5.2B Bet on Liver Disease Treatment Through Akero Acquisition

TradingKey - Danish pharmaceutical giant Novo Nordisk announced on Thursday that it will acquire U.S. biotechnology company Akero Therapeutics for a total consideration of up to $5.2 billion.
Oct 10, 2025

Applied Digital Revenue Surges 84%, Shares Jump 16% After-Hours as AI Data Center Demand Fuels Growth

TradingKey - Applied Digital (APLD.US), which has transformed from a cryptocurrency mining company into an application digital company, reported strong first-quarter earnings that significantly exceeded market expectations, with revenue growth driving its stock price to surge over 16% in after-hours
Oct 10, 2025

Trump Strikes First Drug Deal: Pfizer Cuts Prices in Exchange for Tariff Relief

TradingKey - On Tuesday, U.S. President Donald Trump announced an agreement with Pfizer under which the pharmaceutical giant will voluntarily slash prices for its drugs in the U.S. market.
Oct 1, 2025

Nike's Q1 Gross Margin Defies Tariff Pressure in Early Win for New CEO's Strategy

TradingKey - Nike (NKE) reported better-than-expected first-quarter results for fiscal year 2026 after Tuesday’s market close, offering early evidence that its transformation strategy under new CEO Elliott Hill is gaining traction — even as the company continues to grapple with ongoing tariff press
Oct 1, 2025

Government Shutdown Looms as Senate Fails to Pass Funding Bill

TradingKey - The U.S. government edged closer to a shutdown late Tuesday after the Senate failed to pass a bill aimed at extending funding beyond the midnight deadline.
Oct 1, 2025

YouTube to Pay Trump $24.5 Million to Settle Account Ban Lawsuit

TradingKey - According to court documents, Google-owned video platform YouTube has agreed to pay $24.5 million to settle a lawsuit filed by U.S. President Donald Trump.
Sep 30, 2025

Stripe-OpenAI Pact Reimagines E-commerce with ChatGPT-Powered Etsy Shopping

TradingKey - Payment tech giant Stripe and AI leader OpenAI jointly announced on Monday the official launch of "Instant Checkout" feature based on ChatGPT.
Sep 30, 2025

[U.S. IPO] AstraZeneca Drops ADRs for NYSE Direct Listing; UK Headquarters to Remain

TradingKey - Pharmaceutical giant AstraZeneca announced on Monday a major capital structure adjustment plan, proposing to list its shares directly on the New York Stock Exchange (NYSE) to replace the American Depositary Receipts (ADRs) currently traded by U.S. investors.
Sep 29, 2025

Sony Financial Group shares soar 37% in trading debut, Japan's First Direct Listing in Two Decades

TradingKey - On September 29, Sony Financial Group made its official debut on the Tokyo Stock Exchange's main board, opening at 205 yen — 37% higher than the reference price of 150 yen — and briefly reaching a high of 210 yen during its first day of trading.
Sep 29, 2025

In "Firefighting" Move, Trump Races to Avert Shutdown with Last-Ditch Congressional Talks

TradingKey - U.S. President Donald Trump will urgently convene the four highest-ranking congressional leaders at the White House on Monday, with only 24 hours remaining before federal funding expires. If the two parties fail to reach an agreement, the federal government...
Sep 28, 2025

Meta Bets Billions on Robotics, Aiming to Become the "Android of Robotics"

TradingKey - Building humanoid robots has become Meta's next "AR-level bet." Meta Chief Technology Officer Andrew Bosworth recently provided his first in-depth disclosure that the company has elevated its internally codenamed "Metabot" humanoid robot development to a strategic priority on par...
Sep 28, 2025

CoreWeave Signs $6.5B Deal with OpenAI to Help Reduce Reliance on Microsoft

TradingKey - On Thursday, local time, AI cloud infrastructure provider CoreWeave announced a new cooperation agreement worth $6.5 billion with OpenAI. This latest contract brings the total value of its agreements with the ChatGPT developer to $22.4 billion.
Sep 26, 2025

Trump Unveils 100% Drug Tariffs Effective Oct 1, Domestic Production Becomes Exemption Pathway

TradingKey - U.S. President Donald Trump announced on Thursday that the United States will impose a 100% tariff on "any branded or patented drugs entering the United States" starting October 1.
Sep 26, 2025

After 20-Year Wait, China's Chery Auto Jumps Over 12% in Hong Kong Market Debut

TradingKey - On September 25, Chinese automaker Chery Automobile officially listed on the Hong Kong Stock Exchange, marking a historic milestone for one of China’s “last remaining unlisted major car manufacturers” as it finally fulfilled its long-standing ambition to access the capital markets.
Sep 25, 2025

Following Nvidia's $5B and SoftBank's $2B, Intel seeks investment from Apple: A Path to Recovery?

TradingKey - According to sources familiar with the matter, chipmaker Intel is in talks with Apple to seek investment support for its turnaround plan and to explore deeper collaboration.
Sep 25, 2025

US Antimony Corp Jumps 22% After Securing $245 Million Sole-Source Defense Deal

TradingKey - United States Antimony Corporation (USAC) announced Tuesday that it has signed a five-year, sole-source contract with the U.S. Defense Logistics Agency (DLA) worth up to $245 million to supply antimony metal ingots to the U.S. National Defense Stockpile.
Sep 24, 2025

Trump’s ‘National Capital’ Strategy Targets Lithium with 10% Stake Bid

TradingKey - Shares of pure-play lithium producer Lithium Americas surged more than 80% in after-hours trading on Tuesday, breaking past $5.60 per share. The rally followed market reports that the Trump administration is actively seeking to acquire up to a 10% equity stake in the company.
Sep 24, 2025
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.